Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer

Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer.